Expansion of toxSYN Platform with Best-in-Class Linker Payloads Based on Validated Topiosomerase 1 Inhibitor (Exatecap) & DNA-damaging Agent (Calicheamicin)
Time: 4:15 pm
day: day 1- pm
Details:
- Demonstrating how SYNtecan E™ and SYNeamicin G™ linker-payloads show excellent in vivo efficacy and tolerability
- Immunogenic cell-death driven by SYNtecan E™ ADCs corroborated in syngeneic mouse models
- Discussing how a comprehensive set of linker-payloads enables matching of payload MOA to any clinical indication
